§ BIOTECHNOLOGY
USD · BiotechnologyRIGL
RIGEL PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 1.18
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
89 increased/new, 60 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/E | 2.1 | P/B | 1.99 |
| EPS (TTM) | 18.43 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BlackRock, Inc. | 1.8M | 0.0% | +6% |
| ARMISTICE CAPITAL, LLC | 1.3M | 0.6% | +53% |
| State Street | 1.1M | 0.0% | +3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 764K | n/a | n/a |
| Marshall Wace LLP | 598K | 0.0% | −2% |
| AMERICAN CENTURY COMPANIES INC | 544K | 0.0% | +114% |
◇ AC INTELLIGENCE
Top institutional owners for RIGL as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER97.6% · 0 holders
OTHER1.1% · 88 holders
PASSIVE / INDEX0.5% · 9 holders
DEALER / BANK0.3% · 20 holders
QUALITY / COMPOUNDER0.3% · 13 holders
SYSTEMATIC / QUANT0.2% · 8 holders
ACTIVIST0.1% · 1 holder
TACTICAL / MACRO0.1% · 2 holders
INCOME / DEFENSIVE0.0% · 9 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for RIGL in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention RIGL yet.